Terms: = Gastric cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR
162 results:
1. Preoperative NUn score serves as a robust predictor of overall and disease-specific survivals following radical surgery for gastric cancer.
Urabe M; Okumura Y; Okamoto A; Yajima S; Yagi K; Yamashita H; Seto Y
Langenbecks Arch Surg; 2024 Apr; 409(1):126. PubMed ID: 38619630
[TBL] [Abstract] [Full Text] [Related]
2. Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of car-T cell therapy: a new hope?
Zhang PF; Xie D
Front Immunol; 2024; 15():1362133. PubMed ID: 38558812
[TBL] [Abstract] [Full Text] [Related]
3. [Regimen Selection by Narrative Approach in Patients with Advanced gastric cancer-Paclitaxel or Nab-Paclitaxel?].
Kawase T; Imamura H; Yanagimoto Y; Odagiri K; Suzuki Y; Takeyama H; Yamashita M; Sato Y; Kobayashi A; Ikenaga M; Shimizu J; Akagi K; Iwazawa T; Tomita N; Dono K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):311-313. PubMed ID: 38494815
[TBL] [Abstract] [Full Text] [Related]
4. Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted car-T cell therapy: a case report.
Zhong G; Zhang X; Guo Z; Gao Y; Zhao B; Liu X; Chen L; Qiao J; Yu C; Wang L; Li Y; Yu L
Front Immunol; 2024; 15():1325860. PubMed ID: 38487523
[TBL] [Abstract] [Full Text] [Related]
5. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.
Maia A; Tarannum M; Lérias JR; Piccinelli S; Borrego LM; Maeurer M; Romee R; Castillo-Martin M
Cells; 2024 Mar; 13(5):. PubMed ID: 38474415
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and side effects of anti-CD19 car T-cell therapy in patients with relapsed/refractory gastrointestinal lymphoma.
Jiang YL; Mu J; Cui R; Li X; Wang J; Li Q; Li J; Mou N; Deng Q
Cancer Med; 2024 Feb; 13(4):e7064. PubMed ID: 38457256
[TBL] [Abstract] [Full Text] [Related]
7. Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cancer cells.
Liu CX; Gao Y; Xu XF; Jin X; Zhang Y; Xu Q; Ding HX; Li BJ; Du FK; Li LC; Zhong MW; Zhu JK; Zhang GY
World J Gastroenterol; 2024 Feb; 30(5):485-498. PubMed ID: 38414591
[TBL] [Abstract] [Full Text] [Related]
8. Combined therapy of car-IL-15/IL-15Rα-T cells and GLIPR1 knockdown in cancer cells enhanced anti-tumor effect against gastric cancer.
Ye J; Liu Q; He Y; Song Z; Lin B; Hu Z; Hu J; Ning Y; Cai C; Li Y
J Transl Med; 2024 Feb; 22(1):171. PubMed ID: 38368374
[TBL] [Abstract] [Full Text] [Related]
9. Gut microbiota modulate CD8
Yu X; Ou J; Wang L; Li Z; Ren Y; Xie L; Chen Z; Liang J; Shen G; Zou Z; Zhao C; Li G; Hu Y
Gut Microbes; 2024; 16(1):2307542. PubMed ID: 38319728
[TBL] [Abstract] [Full Text] [Related]
10. Metastatic gastric cancer target lesion complete response with Claudin18.2-car T cells.
Botta GP; Chao J; Ma H; Hahn M; Sierra G; Jia J; Hendrix AY; Nolte Fong JV; Ween A; Vu P; Miller A; Choi M; Heyman B; Daniels GA; Kaufman D; Jamieson C; Li Z; Cohen E
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38316518
[TBL] [Abstract] [Full Text] [Related]
11. carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow-band imaging.
Cho JH; Jin SY; Park S
J Gastroenterol Hepatol; 2024 May; 39(5):942-948. PubMed ID: 38251795
[TBL] [Abstract] [Full Text] [Related]
12. The Future of HER2-Targeted Treatment for Osteosarcoma: Lessons from the Negative Trastuzumab Deruxtecan Results.
Nakano K
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069146
[TBL] [Abstract] [Full Text] [Related]
13. Brave new world-new and emerging treatments for gastric cancer.
Lynch E; Duffy AG; Kelly RJ
Chin Clin Oncol; 2023 Oct; 12(5):54. PubMed ID: 37691344
[TBL] [Abstract] [Full Text] [Related]
14. [Distal pancreatectomy with celiac axis resection for pancreatic body cancer: a single center review of 89 consecutive cases].
Huang XM; Zhang K; Yin J; Wu PF; Cai BB; Lu ZP; Tu M; Chen JM; Guo F; Xi CH; Wei JS; Wu JL; Gao WT; Dai CC; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2023 Oct; 61(10):894-900. PubMed ID: 37653992
[No Abstract] [Full Text] [Related]
15. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
Simon AG; Lyu SI; Laible M; Wöll S; Türeci Ö; Şahin U; Alakus H; Fahrig L; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
J Transl Med; 2023 Aug; 21(1):552. PubMed ID: 37592303
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer.
Dong X; Fan J; Xie W; Wu X; Wei J; He Z; Wang W; Wang X; Shen P; Bei Y
Br J Cancer; 2023 Aug; 129(3):551-562. PubMed ID: 37386139
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of Distal Pancreatectomy With Celiac Axis Resection for Pancreatic cancer.
Shin D; Hong S; Park Y; Kwak BJ; Lee W; Song KB; Lee JH; Kim SC; Hwang DW
Pancreas; 2023 Jan; 52(1):e54-e61. PubMed ID: 37378900
[TBL] [Abstract] [Full Text] [Related]
18. Immunology and immunotherapy in gastric cancer.
Xu X; Chen J; Li W; Feng C; Liu Q; Gao W; He M
Clin Exp Med; 2023 Nov; 23(7):3189-3204. PubMed ID: 37322134
[TBL] [Abstract] [Full Text] [Related]
19. Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer.
Zhang Y; Liang K; Zhou X; Zhang X; Xu H; Dai H; Song X; Yang X; Liu B; Shi T; Wei J
Cancer Sci; 2023 Jul; 114(7):2798-2809. PubMed ID: 37151176
[TBL] [Abstract] [Full Text] [Related]
20. Pancreaticoduodenectomy with celiac artery resection (PD-car) for unresctable locally advanced pancreatic ductal adenocarcinoma.
Kimura K; Amano R; Tauchi J; Nishio K; Ohira G; Shinkawa H; Tanaka S; Yamamoto A; Motomura H; Ishizawa T
Langenbecks Arch Surg; 2023 May; 408(1):174. PubMed ID: 37140679
[TBL] [Abstract] [Full Text] [Related]
[Next]
